FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by AKDIS, C. A.
Right arrow Articles by BLASER, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by AKDIS, C. A.
Right arrow Articles by BLASER, K.
(The FASEB Journal. 1999;13:603-609.)
© 1999 FASEB

Reviews

IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy

CEZMI A. AKDIS and KURT BLASER

Swiss Institute of Allergy and Asthma Research, CH-7270 Davos, Switzerland

Specific immunotherapy (SIT) is widely used for treatment of allergic diseases and could potentially be applied in other immunological disorders. Induction of specific unresponsiveness (anergy) in peripheral T cells and recovery by cytokines from the tissue microenvironment represent two key steps in SIT with whole allergen or antigenic T cell peptides (PIT). The anergy is directed against the T cell epitopes of the respective antigen and characterized by suppressed proliferative and cytokine responses. It is initiated by autocrine action of IL-10, which is increasingly produced by the antigen-specific T cells. Later in therapy, B cells and monocytes also produce IL-10. The anergic T cells can be reactivated by different cytokines. Whereas IL-15 and IL-2 generate Th1 cytokine profile and an IgG4 antibody response, IL-4 reactivates a Th2 cytokine pattern and IgE antibodies. Increased IL-10 suppresses IgE and enhances IgG4 synthesis, resulting in a decreased antigen-specific IgE:IgG4 ratio, as observed normally in patients after SIT or PIT. The same state of anergy against the major bee venom allergen, phospholipase A2, can be observed in subjects naturally anergized after multiple bee stings. Together, these data demonstrate the pivotal role of autocrine IL-10 in induction of specific T cell anergy and the important participation of the cytokine microenvironment in SIT. Furthermore, knowledge of the mechanisms explaining reasons for success or failure of SIT may enable possible predictive measures of the treatment.—Akdis, C. A., Blaser, K. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy.


Key Words: interleukin-10 • T cell epitopes • microenvironments • bee venom




This article has been cited by other articles:


Home page
 Integr Cancer TherHome page
C. Guruvayoorappan
Tumor Versus Tumor-Associated Macrophages: How Hot is the Link?
Integr Cancer Ther, June 1, 2008; 7(2): 90 - 95.
[Abstract] [PDF]

Home page
 ChestHome page
M. Larche
Regulatory T Cells in Allergy and Asthma
Chest, September 1, 2007; 132(3): 1007 - 1014.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Jeal, A. Draper, J. Harris, A. N. Taylor, P. Cullinan, and M. Jones
Modified Th2 Responses at High-Dose Exposures to Allergen: Using an Occupational Model
Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 21 - 25.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
C. Buhot, A. Chenal, A. Sanson, S. Pouvelle-Moratille, M. H. Gelb, A. Menez, D. Gillet, and B. Maillere
Alteration of the tertiary structure of the major bee venom allergen Api m 1 by multiple mutations is concomitant with low IgE reactivity
Protein Sci., November 1, 2004; 13(11): 2970 - 2978.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. W. Steinke, E. Barekzi, J. Hagman, and L. Borish
Functional Analysis of -571 IL-10 Promoter Polymorphism Reveals a Repressor Element Controlled by Sp1
J. Immunol., September 1, 2004; 173(5): 3215 - 3222.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. Akdis, J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, H. Fiebig, et al.
Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells
J. Exp. Med., June 7, 2004; 199(11): 1567 - 1575.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Westritschnig, M. Focke, P. Verdino, W. Goessler, W. Keller, A. Twardosz, A. Mari, F. Horak, U. Wiedermann, A. Hartl, et al.
Generation of an Allergy Vaccine by Disruption of the Three-Dimensional Structure of the Cross-Reactive Calcium-Binding Allergen, Phl p 7
J. Immunol., May 1, 2004; 172(9): 5684 - 5692.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
C. Pilette, S. R. Durham, J.-P. Vaerman, and Y. Sibille
Mucosal Immunity in Asthma and Chronic Obstructive Pulmonary Disease: A Role for Immunoglobulin A?
Proceedings of the ATS, April 1, 2004; 1(2): 125 - 135.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. KUNZMANN, P.-Y. MANTEL, J. G. WOHLFAHRT, M. AKDIS, K. BLASER, and C. B. SCHMIDT-WEBER
Histamine enhances TGF-{beta}1-mediated suppression of Th2 responses
FASEB J, June 1, 2003; 17(9): 1089 - 1095.
[Abstract] [Full Text] [PDF]

Home page
 Epidemiol RevHome page
C. Cole Johnson, D. R. Ownby, E. M. Zoratti, S. Hensley Alford, L. K. Williams, and C. L. M. Joseph
Environmental Epidemiology of Pediatric Asthma and Allergy
Epidemiol. Rev., December 1, 2002; 24(2): 154 - 175.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
N. S. Ostlie, P. I. Karachunski, W. Wang, C. Monfardini, M. Kronenberg, and B. M. Conti-Fine
Transgenic Expression of IL-10 in T Cells Facilitates Development of Experimental Myasthenia Gravis
J. Immunol., April 15, 2001; 166(8): 4853 - 4862.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. J. Till, L. A. Jopling, P. A. Wachholz, R. L. Robson, S. Qin, D. P. Andrew, L. Wu, J. van Neerven, T. J. Williams, S. R. Durham, et al.
T Cell Phenotypes of the Normal Nasal Mucosa: Induction of Th2 Cytokines and CCR3 Expression by IL-4
J. Immunol., February 15, 2001; 166(4): 2303 - 2310.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Vrtala, C. A. Akdis, F. Budak, M. Akdis, K. Blaser, D. Kraft, and R. Valenta
T Cell Epitope-Containing Hypoallergenic Recombinant Fragments of the Major Birch Pollen Allergen, Bet v 1, Induce Blocking Antibodies
J. Immunol., December 1, 2000; 165(11): 6653 - 6659.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Chabot and V. W. Yong
Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: Relevance to MS
Neurology, November 28, 2000; 55(10): 1497 - 1505.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Cottrez, S. D. Hurst, R. L. Coffman, and H. Groux
T Regulatory Cells 1 Inhibit a Th2-Specific Response In Vivo
J. Immunol., November 1, 2000; 165(9): 4848 - 4853.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Astori, C. von Garnier, A. Kettner, N. Dufour, G. Corradin, and F. Spertini
Inducing Tolerance by Intranasal Administration of Long Peptides in Naive and Primed CBA/J Mice
J. Immunol., September 15, 2000; 165(6): 3497 - 3505.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Kahlert, E. Grage-Griebenow, H.-T. Stuwe, O. Cromwell, and H. Fiebig
T Cell Reactivity with Allergoids: Influence of the Type of APC
J. Immunol., August 15, 2000; 165(4): 1807 - 1815.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The Federation of American Societies for Experimental Biology.